PoundsPunch Periodical 2025.03: The Gray Market for "Research Use Only" Weight Loss Drugs Yuchi Song Mar 30, 2025 3 min read Experimental Obesity Drugs Like Retatrutide Are Being Sold for "Research"But Everyone Knows Whats Really Going On Welcome to the March 2025 edition of PoundsPunch
Ferrannini, E., Balkau, B., Coppack, S
Stubborn Fat Deposits and Receptor Distribution Certain fat deposits are notoriously resistant to mobilization through diet and exercise alone
Smoking causes harmful free radicals into the body, further diminishing glutathione's ability to neutralize toxins and protect cells
19-25 Table 4 provides a summary of key warnings and precautions listed in the labeling of each GLP-1 RA product that should be taken into account when considering use in a patient with T2D
For a full breakdown of potential risks, see the Wegovy safety information